|
WO2021057818A1
|
|
Fxia inhibitors and preparation method therefor and pharmaceutical use thereof
|
|
WO2021057661A1
|
|
Pharmaceutical composition for lowering blood sugar
|
|
WO2021052441A1
|
|
Uses of complex of angiotensin ii receptor antagonist metabolite and nep inhibitor in treating heart failure
|
|
WO2020238885A1
|
|
Treatment method of complex of angiotensin ii receptor antagonist metabolite and nep inhibitor
|
|
WO2020238884A1
|
|
New use of complex of angiotensin ii receptor antagonist metabolite and nep inhibitor
|
|
WO2020078170A1
|
|
CRYSTAL FORM α OF COMPOUND A, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING CRYSTAL FORM
|
|
CN112074523A
|
|
Compounds as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation
|
|
CN112074522A
|
|
Compounds as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation
|
|
CN112074521A
|
|
Compounds as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation
|
|
CN109674759A
|
|
A kind of Dapoxetine hydrochloride pharmaceutical composition and preparation method thereof
|
|
CN109865139A
|
|
A kind of compound medicament composition of A Lishatan ester or its salt and calcium-ion channel antagonists
|
|
CN109833481A
|
|
A kind of pharmaceutical composition of A Lishatan ester or its salt and diuretics
|
|
CN109694369A
|
|
A Lishatan ester salt crystal form and pharmaceutical composition containing the salt crystal form
|
|
WO2019047811A1
|
|
Use of docetaxel conjugate in preparation of drug for preventing or treating various immune diseases
|
|
CN111465389A
|
|
Pharmaceutical composition of docetaxel conjugate and preparation method thereof
|
|
CN109692164A
|
|
Compound A or the pharmaceutical composition of its salt and preparation method thereof
|
|
WO2018219295A1
|
|
Deuterated 1,2,4-triazine derivatives of dipeptidyl peptidase iv inhibitor
|
|
CN110546149A
|
|
Piperidines as PCSK9 inhibitors
|
|
CN107200771A
|
|
Preparation and antitumor action of the Docetaxel with the conjugate of muramyl dipeptide simplification thing
|
|
KR20180128393A
|
|
Compounds of Angiotensin II Receptor Antagonist Metabolites and NEP Inhibitors and Methods for its Preparation
|
